JP2002508338A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002508338A5 JP2002508338A5 JP2000538720A JP2000538720A JP2002508338A5 JP 2002508338 A5 JP2002508338 A5 JP 2002508338A5 JP 2000538720 A JP2000538720 A JP 2000538720A JP 2000538720 A JP2000538720 A JP 2000538720A JP 2002508338 A5 JP2002508338 A5 JP 2002508338A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- hiv
- composition according
- lentivirus
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6957997P | 1997-12-12 | 1997-12-12 | |
| US60/069,579 | 1997-12-12 | ||
| PCT/US1998/025720 WO1999030742A1 (en) | 1997-12-12 | 1998-12-11 | Therapeutic use of lentiviral vectors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002508338A JP2002508338A (ja) | 2002-03-19 |
| JP2002508338A5 true JP2002508338A5 (https=) | 2006-01-26 |
Family
ID=22089926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000538720A Pending JP2002508338A (ja) | 1997-12-12 | 1998-12-11 | レンチウィルスベクターの治療使用 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1037669A4 (https=) |
| JP (1) | JP2002508338A (https=) |
| KR (1) | KR20010033062A (https=) |
| AU (1) | AU749059B2 (https=) |
| CA (1) | CA2314683A1 (https=) |
| WO (1) | WO1999030742A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2388337C (en) | 1999-10-22 | 2013-01-08 | Aventis Pasteur Limited | Method of inducing and/or enhancing an immune response to tumor antigens |
| US6656706B2 (en) | 1999-12-23 | 2003-12-02 | The United States Of America As Represented By The Department Of Health And Human Services | Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes |
| DK1282702T3 (da) | 2000-05-10 | 2007-04-02 | Sanofi Pasteur Ltd | Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf |
| US6712612B1 (en) | 2000-12-12 | 2004-03-30 | Genecure Llc | Safe and stable retroviral helper cell line and related compositions and methods |
| AU2003300076C1 (en) | 2002-12-30 | 2010-03-04 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| ES2298745T3 (es) | 2003-04-24 | 2008-05-16 | Fondazione Centro San Raffaele Del Monte Tabor | Promotores bidireccionales de sintesis y utilizacion de los mismos. |
| JP2011500036A (ja) | 2007-10-15 | 2011-01-06 | ザ ユニバーシティー オブ クイーンズランド | 構築物系およびその使用 |
| US9795658B2 (en) | 2010-04-20 | 2017-10-24 | Admedus Vaccines Pty Ltd | Expression system for modulating an immune response |
| WO2017096432A1 (en) | 2015-12-09 | 2017-06-15 | Admedus Vaccines Pty Ltd | Immunomodulating composition for treatment |
| WO2018018082A1 (en) | 2016-07-26 | 2018-02-01 | The Australian National University | Immunostimulatory compositions and uses therefor |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4955096A (en) * | 1995-03-16 | 1996-10-02 | Hisamitsu Pharmaceutical Co., Inc. | Novel gene recombinant |
| US5650309A (en) * | 1995-05-16 | 1997-07-22 | The Regents Of The University Of California | Viral vectors |
| US6013516A (en) * | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| AU1123497A (en) * | 1995-11-28 | 1997-06-19 | Clinical Technologies, Inc. | Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
| JP2000503527A (ja) * | 1995-11-28 | 2000-03-28 | ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン | 条件付き複製ウイルスベクターおよびその用途 |
| NZ331369A (en) * | 1996-02-21 | 2001-04-27 | Franco Lori | Use of a genetic construct that directs virus expression in a lymphoid organ or a transduced cell thereof for genetic immunization |
| CA2247091A1 (en) * | 1996-03-05 | 1997-09-12 | The Regents Of The University Of California | Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| ATE359372T1 (de) * | 1996-07-22 | 2007-05-15 | Us Gov Health & Human Serv | Vektoren zur inhibierung von viralem und tumorwachstum |
| EP0991771A2 (en) * | 1997-03-06 | 2000-04-12 | Klaus Überla | Lentivirus based vector and vector system |
| GB9704977D0 (en) * | 1997-03-11 | 1997-04-30 | Univ Glasgow | FIV vaccine |
| EP1003894A2 (en) * | 1997-07-18 | 2000-05-31 | Chiron Corporation | Lentiviral vectors |
-
1998
- 1998-12-11 AU AU18035/99A patent/AU749059B2/en not_active Ceased
- 1998-12-11 CA CA002314683A patent/CA2314683A1/en not_active Abandoned
- 1998-12-11 WO PCT/US1998/025720 patent/WO1999030742A1/en not_active Ceased
- 1998-12-11 EP EP98962895A patent/EP1037669A4/en not_active Withdrawn
- 1998-12-11 KR KR1020007006423A patent/KR20010033062A/ko not_active Withdrawn
- 1998-12-11 JP JP2000538720A patent/JP2002508338A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002317841A1 (en) | Use of fkbp chaperones as expression tool | |
| ATE264914T1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
| EA200200724A1 (ru) | Вакцина для профилактической или терапевтической иммунизации против вируса иммунодефицита человека (вич) | |
| ES2113854T3 (es) | Derivados de albumina con funciones terapeuticas. | |
| MXPA02007478A (es) | Vacuna contra el virus de inmunodeficiencia humana. | |
| JP2002508338A5 (https=) | ||
| BG102048A (en) | Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors | |
| EA200001030A1 (ru) | Получение капсул и таблеток быстрорастворяющегося эфавиренза с использованием супердезинтеграторов | |
| WO1999065870A3 (en) | Sulfonamide inhibitors of aspartyl protease | |
| MY137777A (en) | Inhibitors of aspartyl protease | |
| AU3485800A (en) | Inhibitors of aspartyl protease | |
| RU96116005A (ru) | Штамм hominis immunodeficiti virus (hiv-i) вич-i/россия/гм-12-95 (ru1295) субтипа в для диагностических и вакцинных препаратов | |
| WO2000061067A3 (fr) | Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1 | |
| NO940810L (no) | Behandling av virusinfeksjoner | |
| CA2195125A1 (en) | Difluorostatone antiviral agents | |
| BG101175A (bg) | Тройна анти-нiv комбинация | |
| JP2002523426A5 (https=) | ||
| EP0323157A3 (en) | Antiviral compounds and methods | |
| WO2000018433A3 (en) | Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine | |
| ATE509942T1 (de) | Nichtproteolysierbare oligopeptide, die das glycoprotein gp41 von hiv inhibieren | |
| FI881123L (fi) | Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar. | |
| RU2003125554A (ru) | Природные антитела, активные против вируса иммунодефицита человека (вич) | |
| FR2647809B1 (fr) | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus | |
| FR2652091B1 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus. | |
| WO1999061011A3 (de) | Verwendung eines arzneimittels mit einem gehalt an tyrothricin zur behandlung von virusinfektionen |